Tesevatinib is a quinazoline-based compound that functions as a multi-target tyrosine kinase inhibitor, targeting receptors such as EGFR, ErbB2, KDR, Flt4, and EphB4. It is investigated for its anticancer properties and is used as a pharmaceutical raw material or research compound.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Diclofenac diethylamine
pharmaceutical raw material
Paroxetine hydrochloride
pharmaceutical raw material
Rosiptor
pharmaceutical raw material
Nepafenac
pharmaceutical raw material
The international HS code for N-(3,4-dichloro-2-fluorophenyl)-6-methoxy-7-(((3aR,6aS)-2-methyloctahydrocyclopenta(c)pyrrol-5-yl)methoxy)-4-quinazolinamine (CAS 781613-23-8) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
7-[[(3aS,6aR)-2-methyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrol-5-yl]methoxy]-N-(3,4-dichloro-2-fluorophenyl)-6-methoxyquinazolin-4-amine
HVXKQKFEHMGHSL-GOOCMWNKSA-N
CN1C[C@H]2CC(C[C@H]2C1)COC3=C(C=C4C(=C3)N=CN=C4NC5=C(C(=C(C=C5)Cl)Cl)F)OC
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.